Overview: |
Title: Charted territory: Inflation playbook |
Date: Wednesday, March 30, 2022 |
Time: 1:00 PM Eastern Daylight Time |
Duration: 1 hour |
Register Now: |
Already Registered? |
Summary: |
||
Now On Demand. Inflation remains the player to watch this season when considering the market environment ahead. For the first time in a generation, investors are facing sustained higher inflation. What does this mean for the economy, the market, and investors? Join Chief U.S. Economist Lara Rhame and Kara O’Halloran as they tackle the following topics:
|
||
Speakers: |
||
|
||
Lara is Chief U.S. Economist and Managing Director on the Investment Research team at FSInvestments, where she analyzes developments in the global and U.S. economy and financial markets. Her fresh take on macroeconomic issues helps to inform and develop the firm’s long-term views on the economy, investment trends and issues facing investors. Lara is committed to the Philadelphia community and serves on the boards of the Economy League of Greater Philadelphia, Hyperion Bank and Starr Garden Park. |
||
|
||
Kara is a Director on the Investment Research team at FS Investments, where she leads research efforts on the corporate credit sector and helps develop strategic education on liquid alternatives. She holds bachelor’s degrees in Finance and Accounting from Villanova University and has experience investing private credit funds and in public accounting. Kara is a Co-Chair of the FS Women’s Network and also volunteers with the firm’s financial literacy and education programs. |
CONFIDENTIAL. FOR FINANCIAL PROFESSIONAL USE ONLY. NOT FOR INVESTOR USE.
Securities offered through FS Investment Solutions, LLC (member FINRA/SIPC). FS Investment Solutions, LLC is an affiliated broker-dealer that serves as the wholesaling distributor of non-traded funds sponsored by FS Investments. An investment in any fund sponsored by FS Investments involves a high degree of risk and may be considered speculative. Investors are advised to consider the investment objectives, risks, and charges and expenses of the applicable fund carefully before investing. The applicable fund’s prospectus contains this and other information. Investors may obtain a copy of the applicable fund’s prospectus free of charge at www.fsinvestments.com or by contacting FS Investments at 201 Rouse Blvd., Philadelphia, PA 19112 or by phone at 877-628-8575. Investors should read and carefully consider all information found in the applicable fund’s prospectus and other reports filed with the U.S. Securities and Exchange Commission before investing.
This is neither an offer to sell nor a solicitation of an offer to buy the securities described herein. An offering is made only by a prospectus, which must be made available to you in connection with this offering. No offering is made to New York investors except by a prospectus filed with the Department of Law of the State of New York.
This email and any attachments are intended only for the use of the addressee and may contain information that is privileged and confidential. If the reader of this email is not the intended recipient or an authorized representative of the intended recipient, you are hereby notified that any use, review, retransmission, dissemination, distribution, copying, printing, or any other use or action taken in reliance upon this email is strictly prohibited. If you have received this email in error, please notify the sender immediately by replying to this email message or by telephone at 877-628-8575 and delete this email and any attachments from your system. The contents of any email and its attachments which are sent by or to the sender may be subject to monitoring, review and archive. Any statements or opinions expressed in this email are those of the sender and do not necessarily represent those of sender’s employer, its affiliated companies or any other person. Although the sender’s employer attempts to sweep email and attachments for viruses, it does not guarantee that either is virus-free and accepts no liability for any damages as a result of viruses.